Insulin :: Lilly Introduces World’s First Digital Insulin Pen With Memory
Eli Lilly and Company today announced the launch of the first insulin pen with memory, HumaPen? MEMOIR?, to help simplify the daily management of diabetes.
Medical
Herpes :: Herpes treatment could slow HIV progression
The association between genital herpes and higher viral loads of HIV-1 in HIV-infected persons is strong enough to warrant more routine testing for the herpes virus in HIV-positive patients, as well as additional clinical studies of the co-infections, according to an editorial to be published in the New England Journal of Medicine.
Anemia :: Roche suspends enrollment for anemia drug trial
Roche announced that it is temporarily suspending recruitment into its Phase II dose-finding study (NH19960) with the investigational drug C.E.R.A. in anaemic patients with advanced non small cell lung cancer receiving chemotherapy.
Prostate :: Way to identify which men need a second prostate biopsy
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
Heart :: MUSC helps turn heart guidelines into lifelines
The Medical University of South Carolina, (MUSC) was recognized for participating in an American Heart Association and American Stroke Association program called Get With the Guidelines.
Colon Cancer :: 12 myths about colon cancer
Colon cancer is the second leading cause of cancer death in the United States, and the No. 1 cause of cancer death among non-smokers.
Asthma :: Significant asthma control and improved lung function with Symbicort
Data show significant asthma control and improved lung function with Symbicort.
Lung Cancer :: Avastin with chemotherapy shows improved progression in lung cancer patients
Genentech, Inc. (NYSE: DNA) announced that a Roche-sponsored Phase III study evaluating two different doses of Avastin(R) (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy met the primary endpoint of prolonging progression-free survival (PFS) in patients with previously untreated, advanced non-squamous, non-small cell lung cancer (NSCLC), the most common form of the disease.
Oncology :: Recruitment suspended into C.E.R.A. Phase II Oncology Trial
Roche announced that it is temporarily suspending recruitment into its Phase II dose-finding study (NH19960) with the investigational drug C.E.R.A. in anaemic patients with advanced non small cell lung cancer receiving chemotherapy.
Lipitor :: Danish Court prohibits sale of generic Lipitor product
Pfizer Inc said that a Danish court has granted a preliminary injunction against Nomeco A/S — the largest pharmaceutical wholesaler in Denmark — that prohibits the sale of a generic version of Lipitor by generics manufacturer Ranbaxy.